Tabula Rasa HealthCare Inc (NASDAQ:TRHC) CEO Calvin H. Knowlton sold 8,000 shares of the business’s stock in a transaction dated Thursday, February 7th. The stock was sold at an average price of $52.73, for a total transaction of $421,840.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
NASDAQ TRHC traded up $1.15 on Monday, reaching $53.96. The company’s stock had a trading volume of 687,087 shares, compared to its average volume of 361,310. The stock has a market cap of $1.08 billion, a P/E ratio of -1,349.00, a PEG ratio of 3.35 and a beta of 1.79. Tabula Rasa HealthCare Inc has a 52 week low of $28.55 and a 52 week high of $91.16. The company has a quick ratio of 0.46, a current ratio of 0.49 and a debt-to-equity ratio of 0.28.
TRHC has been the topic of several research reports. BidaskClub upgraded shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a report on Wednesday, November 28th. Chardan Capital boosted their price objective on shares of Tabula Rasa HealthCare from $77.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, November 7th. Cantor Fitzgerald reissued a “buy” rating and issued a $99.00 target price on shares of Tabula Rasa HealthCare in a research note on Tuesday, November 6th. Benchmark assumed coverage on shares of Tabula Rasa HealthCare in a research note on Tuesday, January 8th. They issued a “buy” rating and a $85.00 target price on the stock. Finally, Zacks Investment Research raised shares of Tabula Rasa HealthCare from a “sell” rating to a “buy” rating and set a $69.00 target price on the stock in a research note on Thursday, January 10th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $82.27.
A number of hedge funds and other institutional investors have recently bought and sold shares of TRHC. First Mercantile Trust Co. bought a new stake in Tabula Rasa HealthCare in the fourth quarter valued at about $39,000. TCI Wealth Advisors Inc. grew its stake in Tabula Rasa HealthCare by 1,600.0% during the fourth quarter. TCI Wealth Advisors Inc. now owns 850 shares of the company’s stock worth $54,000 after buying an additional 800 shares during the last quarter. Quantamental Technologies LLC bought a new stake in Tabula Rasa HealthCare during the fourth quarter worth about $64,000. Oppenheimer Asset Management Inc. bought a new stake in Tabula Rasa HealthCare during the fourth quarter worth about $135,000. Finally, LS Investment Advisors LLC grew its stake in Tabula Rasa HealthCare by 19.9% during the fourth quarter. LS Investment Advisors LLC now owns 2,813 shares of the company’s stock worth $179,000 after buying an additional 466 shares during the last quarter. 79.23% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This report was posted by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at https://www.americanbankingnews.com/2019/02/11/calvin-h-knowlton-sells-8000-shares-of-tabula-rasa-healthcare-inc-trhc-stock.html.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.
Recommended Story: How analysts view the yield curve
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.